Precision Genetic Engineering for Gut Microbiome & Live Biotherapeutic Development

As a specialized Contract Research Organization (CRO), Creative Biolabs understands that the future of medicine lies within the intricate ecosystems of the human body. The gut microbiome, often referred to as our "second genome," has emerged as a cornerstone of human health, influencing everything from metabolic homeostasis and immune regulation to neurological signaling via the gut-brain axis. As the field shifts from purely observational studies to functional interventions, the demand for precision-engineered microbial solutions has never been higher.

Our Genetic Engineering for Gut Microbiome Engineering service is designed to bridge the gap between synthetic biology and clinical application. We provide a comprehensive suite of tools to transform commensal bacteria into intelligent, programmable "living factories" capable of sensing, responding to, and treating disease from within.

Fig.1 Genetic modification. (Creative Biolabs Authorized)

Overview: Redefining the Microbiome

Our genetic engineering service offers a robust platform for the modification of diverse microbial species found within the human gastrointestinal tract. By utilizing advanced genome editing technologies, we empower researchers to go beyond traditional probiotics. We help you design and create Live Biotherapeutic Products (LBPs) that can deliver therapeutic payloads, such as anti-inflammatory cytokines, short-chain fatty acids (SCFAs), or enzymatic inhibitors, directly to the site of interest.

The core of our mission is precision. Whether you are looking to knock out a specific metabolic pathway that contributes to toxicity or knock in a synthetic gene circuit to act as a diagnostic biosensor, our team of molecular biologists and microbiologists provides the technical expertise to turn your hypothesis into a validated lead candidate.

Service Portfolio: Technical Capabilities

Host Strain Selection and Characterization

Success starts with the right chassis. We work with a wide range of strains, including:

  • Model Organisms: Escherichia coli Nissle 1917, Bacteroides thetaiotaomicron.
  • Commensal Strains: Lactobacillus, Bifidobacterium, and Akkermansia muciniphila.
  • Strict Anaerobes: Specialized handling for delicate anaerobic species essential for gut health.

Advanced Genome Editing

We utilize state-of-the-art tools to ensure high-efficiency modifications:

  • Marker-free Editing: Using gene editing systems to create clean deletions or insertions without leaving antibiotic resistance markers, adhering to safety standards.
  • In situ Engineering: Developing conjugation-based systems to deliver genetic material to established microbial communities.
  • Large Fragment Integration: Capability to integrate complex multi-gene metabolic pathways.

Synthetic Gene Circuit Design

We build "smart" bacteria that only work when and where they are needed:

  • Inducible Promoters: Circuits that respond to specific triggers, such as bile salts, inflammation markers (NO, tetrathionate), or exogenous signals like dietary components.
  • Kill Switches: Essential safety features that allow for the controlled elimination of the engineered strain from the host after the therapeutic window.

Expression Optimization and Metabolic Engineering

  • Codon Optimization: Tailoring gene sequences for maximum expression in the target host.
  • Metabolic Flux Analysis: Ensuring that the production of the therapeutic molecule does not compromise the fitness or colonization ability of the microbe.

Related Products for Preclinical Studies

To support our engineering services, we provide a catalog of standardized products designed to streamline your preclinical research:

  • Standardized "Chassis" Strains: Pre-characterized microbial strains ready for transformation.
  • Microbial Expression Vectors: A library of promoters and signal peptides optimized for various gut bacteria.
  • Metabolite Standards: High-purity SCFAs and other microbial byproducts for validation assays.

Platform Advantages: Why Partner with Us?

Working with a CRO that understands both the biology and the engineering is critical. Our platform offers several key advantages:

Precision and Stability

Our genome-integrated modifications are more stable than plasmid-based systems, ensuring the therapeutic effect lasts throughout the colonization period.

Regulatory Alignment

We prioritize marker-free and biocontainment strategies from day one, facilitating a smoother transition to IND-enabling studies.

Deep Anaerobic Expertise

Our facility is equipped with specialized anaerobic chambers and fermentation systems, allowing us to engineer the "dark matter" of the microbiome that many other labs cannot handle.

Integrated Analytical Suite

We don't just engineer the strain; we validate it. Our platform includes transcriptomics, metabolomics, and in vivo colonization assays to prove efficacy.

Applications

The versatility of engineered gut microbes allows for applications across a broad spectrum of therapeutic areas:

  • Metabolic Diseases: Engineering bacteria to degrade excess ammonia, oxalate, or phenylalanine to treat rare metabolic disorders.
  • Inflammatory Bowel Disease (IBD): Localized delivery of IL-10 or other anti-inflammatory agents to the intestinal mucosa.
  • Immuno-Oncology: Modulating the gut environment to enhance the efficacy of checkpoint inhibitors or delivering tumor-targeting molecules.
  • Gut-Brain Axis: Producing neurotransmitters or precursors to treat neurological and psychiatric conditions via the enteric nervous system.
  • Anti-Infectives: Creating "sentinel" bacteria that detect and kill pathogens like C. difficile through the production of targeted bacteriocins.

The Science of Microbiome Engineering

For decades, researchers relied on fecal microbiota transplants (FMT) or natural probiotics to modulate gut health. While effective, these methods lack precision and consistency. The rise of Synthetic Biology has changed the landscape.

The potential of the gut microbiome to serve as a platform for next-generation medicine is immense. By combining your innovative ideas with our robust genetic engineering infrastructure, we can create precision therapies that truly change patient lives. Whether you are a biotech startup or an established pharmaceutical company, we are here to provide the technical backbone for your microbiome-based drug development journey.

Reach out to our scientific team today to discuss how we can bring your engineered microbial vision to life.

Frequently Asked Questions (FAQs)

Can you engineer strictly anaerobic bacteria found in the human gut?

Yes. We have specialized anaerobic facilities and have developed proprietary transformation protocols for various "hard-to-transform" anaerobes, including members of the Bacteroidetes and Firmicutes phyla.

How do you ensure the engineered strain doesn't transfer its DNA to the native microbiota?

We employ several strategies, including chromosomal integration (which is much less likely to transfer than plasmids) and the use of "non-mobilizable" genetic elements. We can also design strains with metabolic dependencies that prevent them from surviving outside the lab or a specific host environment.

Do you provide in vivo testing for the engineered strains?

Absolutely. As a full-service CRO, we offer germ-free and humanized mouse models to evaluate colonization, stability, and therapeutic efficacy of your engineered leads.

What is the typical timeline for a custom engineering project?

Timelines vary based on the complexity of the modification and the growth rate of the host strain, but a typical project from design to validated clone takes approximately 12 to 24 weeks.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Creative Biolabs-Live Biotherapeutics


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2026 Creative Biolabs. All Rights Reserved.

Inquiry Basket